Submit your image related to Diseases to be featured!

Get Social

Submit your Twitter account related to Stage Ii Ovarian Cancer to be featured!


Submit your blog on Stage Ii Ovarian Cancer to be featured!


Submit your event on Stage Ii Ovarian Cancer to be featured!


Submit your video on Stage Ii Ovarian Cancer to be featured!


Submit your charity on Stage Ii Ovarian Cancer to be featured!

Stage Ii Ovarian Cancer: Disease Bioinformatics

Ovarian cancer begins in the ovaries but is typically undetected until it is found in the pelvis and abdomen, making it difficult to treat and commonly fatal. There are three types of ovarian cancer that differentiate depending on location of where it began: cancer than begins in the cells on the outside of the ovaries, cancer that begins in the egg-producing cells, and cancer that begins in the hormone-producing cells. Risk factors for ovarian cancer include inherited gene mutations, a family history of ovarian cancer, increasing age, and never being pregnant. Treatments for ovarian cancer most frequently include surgery and chemotherapy. Stage II ovarian cancer occurs when cancer is present in both ovaries and has spread to other organs and tissues within the pelvis, yet not to the lymph nodes, distant sites or organs, or the lining of the abdomen. Stage II can be divided into three subgroups. Stage IIA occurs when the cancer is located in the uterus and/or fallopian tubes. Stage IIB is characterized by cancer in pelvic organs (bladder, rectum). Stage IIC is when cancer has spread to pelvic organs (like in IIA and IIB) and cancer cells were found when the fluid from the washings from the abdomen were examined.

Stage Ii Ovarian Cancer Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Ovarian Cancer below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 147 products for the study of Stage Ii Ovarian Cancer that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.

Western Blot: NLRP5 Antibody [NBP1-76289] - Mouse brain tissue lysate with NLRP5 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.Immunohistochemistry: NLRP5 Antibody [NBP1-76289] - Immunohistochemistry of NALP5 in human brain tissue with NALP5 antibody at 10 ug/mL.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, ELISA, ICC/IF

Western blot shows lysates of Capan‑1 human pancreatic adenocarcinoma cell line, HeLa human cervical epithelial carcinoma cell line, and U2OS human osteosarcoma cell line. PVDF membrane was probed with 0.2 µg/mL of Human BRCA2 Monoclonal Antibody (Catalog # MAB2476) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # <a class=

Mouse Monoclonal
Species Human
Applications WB, IHC

2 Publications
Western Blot: BRCA1 Antibody (17F8) [NBP1-41185] -  A: 293T B: HeLa.Chromatin Immunoprecipitation: BRCA1 Antibody (17F8) [NBP1-41185] - ChIP grade BRCA1 antibody 6B4  and BRCA1 antibody 17F8 were used for ChIP assay. The 6B4 and 17F8 mixture (3 microgram each), or normal mouse IgG (6 microgram) were incubated with HeLa chromatin extract (100 umicrogram each) in the ChIP assay. Enrichment of genomic DNA on a BRCA1 target gene promoter (HMGA2) was validated by a Q-PCR assay.

Mouse Monoclonal
Species Human, Mouse
Applications WB, ChIP, ELISA

9 Publications

Related Genes

Stage Ii Ovarian Cancer has been researched against:

Related Pathways

Related PTMs

Alternate Names

Stage Ii Ovarian Cancer is also known as Figo Stage Ii Ovarian Cancer, Figo Stage Ii Ovarian Carcinoma, Ovarian Cancer Stage Ii, Stage Ii Ovarian Carcinoma.